Monthly Archives: February 2024

//February

Call to put primary and community services at core of health and care system

In a new report, The King’s Fund has called for the health and care system in England to be radically refocused to put primary and community care at its core to make it effective and sustainable. The report authors argue that the failure to grow and invest in primary and community health and care services, [...]

The post Call to put primary and community services at core of health and care system appeared first on Community Pharmacy England.

By |February 14th, 2024|Lexpos News|Comments Off on Call to put primary and community services at core of health and care system

Medicine Supply Notification: Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials MSN/2024/021 Tier 3 – high impact Date of issue 21st February 2024 Link: Medicines Supply Tool Summary Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid is in very limited supply with a resolution date [...]

The post Medicine Supply Notification: Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials appeared first on Community Pharmacy England.

By |February 14th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials

Medicine Supply Notification: Lisdexamfetamine (Elvanse®) capsules

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Lisdexamfetamine (Elvanse®) capsules. MSN/2024/019 Tier 3 – high impact  Date of issue 13th February 2024 There will be intermittent supply of all strengths of lisdexamfetamine (Elvanse®) capsules until April 2024. Supplies of various strengths of Elvanse® will be available at different [...]

The post Medicine Supply Notification: Lisdexamfetamine (Elvanse®) capsules appeared first on Community Pharmacy England.

By |February 13th, 2024|Lexpos News|Comments Off on Medicine Supply Notification: Lisdexamfetamine (Elvanse®) capsules

MHRA Class 3 Medicines Recall: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited)

Drug alert number: EL (24)A/05 Date issued: 12 February 2024 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited) PL 36687/0222 SNOMED Code: 36834211000001109 Batch Number Expiry Date Pack Size First Distributed MG21264 29/02/2024 28 tablets 13/12/2021 MG21334 31/03/2024 28 tablets [...]

The post MHRA Class 3 Medicines Recall: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited) appeared first on Community Pharmacy England.

By |February 13th, 2024|Lexpos News|Comments Off on MHRA Class 3 Medicines Recall: Ramipril 1.25mg tablets (Torrent Pharma (UK) Limited)

February 2024 Price Concessions 1st Update

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (13/02/2024) announced the following initial list of price concessions for February 2024. Drug Pack size Price concession Atorvastatin 80mg tablets 28 £2.64 Azithromycin 250mg capsules 6 £4.67 Bimatoprost [...]

The post February 2024 Price Concessions 1st Update appeared first on Community Pharmacy England.

By |February 13th, 2024|Lexpos News|Comments Off on February 2024 Price Concessions 1st Update